p53 expression in patients with malignant and benign breast diseases

Citation
A. Kalogeraki et al., p53 expression in patients with malignant and benign breast diseases, ANTICANC R, 20(3A), 2000, pp. 1801-1805
Citations number
41
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
20
Issue
3A
Year of publication
2000
Pages
1801 - 1805
Database
ISI
SICI code
0250-7005(200005/06)20:3A<1801:PEIPWM>2.0.ZU;2-M
Abstract
Immunohistochemical expression of p53 protein was studied in FNA specimens of 20 breast ductal carcinomas, 20 fibroadenomas and 20 atypical ductal hyp erplasia of the breast. Nine cases of breast carcinomas (45%), five fibroad enomas (25%) and four atypical ductal hyperplasia (20%) were found to be p5 3-immuno-positive. A statistically significant difference was found among p 53 staining index of breast carcinomas (mean 72,55%), fibroadenomas (mean 4 1,2%) and atypical ductal hyperplasia (mean 34%). Variations in p53 express ion among individual breast carcinomas was found, and these variations may correlate with prognosis.